During the past decade, Jonathan Corren MD, Inc. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jonathan Corren MD, Inc." #1 sponsor was "Aimmune Therapeutics, Inc." with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Amgen" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Kindeva Drug Delivery" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Jonathan Corren MD, Inc." are "Asthma" (3 trials), "Peanut Allergy" (3 trials), "Chronic Rhinosinusitis" (2 trials), "Nasal Polyps" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Jonathan Corren MD, Inc." in a lesser frequency.

Most popular intervention types in "Jonathan Corren MD, Inc." are "Drug" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "AR101" (3 trials), "Omalizumab" (3 trials), "MSTT1041A" (2 trials) and "Budesonide/Formoterol fumarate dihydrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jonathan Corren MD, Inc." are 10 trials for "All" genders.

Currently, there are NaN active trials in "Jonathan Corren MD, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Jonathan Corren MD, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jonathan Corren MD, Inc., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".